Concepedia

Petra Heffeter

PH

140

Publications

7.1K

Citations

50

H-Index

2004

Active since

Affiliations

Medical University of Vienna(Current)

University of Vienna

Comprehensive Cancer Center Vienna

BOKU University

Institute of Inorganic Chemistry of the Slovak Academy of Sciences

Petra Heffeter is an author at Medical University of Vienna specializing in medicine, pharmacology, and cell biology.

ORCID

Top concepts

Publications per year

2004–2024

140

Publications

140

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

Robert Trondl, Petra Heffeter, Christian R. Kowol et al. · Chemical Science · 2014 · 652 citations · Full text

, , +16

Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

Susanne Kapitza, M. Pongratz, Michael A. Jakupec et al. · Journal of Cancer Research and Clinical Oncology · 2004 · 197 citations · Full text

, , +9

Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339

Petra Heffeter, Katharina Böck, Bihter Atil et al. · JBIC Journal of Biological Inorganic Chemistry · 2010 · 167 citations

, , +12

Impact of Metal Coordination on Cytotoxicity of 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone (Triapine) and Novel Insights into Terminal Dimethylation

Christian R. Kowol, Robert Trondl, Petra Heffeter et al. · Journal of Medicinal Chemistry · 2009 · 159 citations

Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds

Christian R. Kowol, Petra Heffeter, Walter Miklos et al. · JBIC Journal of Biological Inorganic Chemistry · 2011 · 146 citations

, , +9

Rows per page

1–5 of 140